logo
Plus   Neg
Share
Email

Geron Gets EMA COMP Positive Opinion For Imetelstat Orphan Drug Designation

Geron Corp. (GERN), a late-stage clinical biopharmaceutical company, said Wednesday that the European Medicines Agency or EMA Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on the company's application for orphan drug designation of its first-in-class telomerase inhibitor, Imetelstat, as a potential treatment for myelodysplastic syndromes or MDS.

Geron said that based on the COMP positive opinion, it expects that the European Commission will formally grant the orphan drug designation for the European Union or EU by the end of July. The designation will provide a 10-year period of marketing exclusivity in the EU after product approval.

Imetelstat has already been granted orphan drug designation by the U.S. Food and Drug Administration as a potential treatment for MDS.

MDS is a group of blood disorders in which the proliferation of malignant progenitor cells produces multiple malignant cell clones in the bone marrow. This will result in disordered and ineffective production of the myeloid lineage, including red blood cells, white blood cells and platelets. Chronic anemia is the predominant clinical problem in patients who have lower risk MDS.

Geron also said that patients are currently enrolling in a company-sponsored Phase 3 clinical trial in lower risk MDS.

The IMerge Phase 3 clinical trial is a double-blind, randomized, placebo-controlled clinical trial with registration intent. The trial is designed to enroll about 170 patients with lower risk transfusion dependent MDS who are relapsed or refractory to an ESA, have not received prior treatment with either a hypomethylating agent or HMA, or lenalidomide, and who are non-del(5q).

Geron expects to complete patient enrollment by the end of the first quarter of 2021 and the top-line results to be available in the second half of 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
After providing free and discounted rides to the polls on Election Day, Lyft is now set to support voters with discounted rides to the polls for the federal runoff races in Louisiana and Georgia. They also provided similar rides during the primary season. The ride-sharing company is continuing its Voting Access Program to provide affordable transportation to voters in need. Discount retailer Dollar General Corp. and supermarket chain Kroger Co. on Thursday reported sharp increases in their quarterly profits on higher sales. While Dollar General's results trounced analysts' estimates, Kroger's earnings beat expectations while revenue fell short. Dollar General's profit for the third quarter surged 57 percent from last year. On January 4, 2021, Discovery plans to launch its new standalone streaming service called Discovery+ which will also offer exclusive streaming access to the BBC's award-winning natural history shows like Planet Earth, Blue Planet, and Frozen Planet. The channel is expected to offer the largest content of real-life entertainment provided by any streaming platform at launch.
Follow RTT